1. Gene
  2. DUS2 - dihydrouridine synthase 2 Gene

DUS2 - dihydrouridine synthase 2 Gene

Homo sapiens

Also known as SMM1; DUS2L; URLC8

Gene ID: 54920 | Gene type: protein coding

About DUS2

Cytogenetic location: 16q22.1 Genomic coordinates (GRCh38): 16:68,023,284-68,079,320 (from NCBI)

This gene has 16 transcripts (splice variants), 200 orthologues and 3 paralogues. Broad expression in testis (RPKM 12.7), lymph node (RPKM 5.7) and 24 other tissues.

Summary

This gene encodes a cytoplasmic protein that catalyzes the conversion of uridine residues to dihydrouridine in the D-loop of tRNA. The resulting modified bases confer enhanced regional flexibility to tRNA. The encoded protein may increase the rate of translation by inhibiting an interferon-induced protein kinase. This gene has been implicated in pulmonary carcinogenesis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Nov 2012]

DUS2 Products(3)

mRNA Protein Name
NM_001271762.2 NP_001258691.1 tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform 1
NM_001271763.2 NP_001258692.1 tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform 2
NM_017803.5 NP_060273.1 tRNA-dihydrouridine(20) synthase [NAD(P)+]-like isoform 1

DUS2 Protein Structure

Dus

Dus: Dihydrouridine synthase (Dus) (15 - 329)

dsrm

dsrm: Double-stranded RNA binding motif (370 - 432)

  • 0
  • 100
  • 200
  • 300
  • 400
  • 493 a.a.
Protein Preferred Names Protein Names

tRNA-dihydrouridine(20) synthase [NAD(P)+]-like

SMM1 homolog

Related Diseases

Diseases Alias
Lung Cancer

Lung Carcinoma

Non-Small Cell Lung Carcinoma

Lung Cancer, Susceptibility To

Lung Cancer, Protection Against

Adenocarcinoma Of Lung, Somatic

Adenocarcinoma Of Lung, Response To Tyrosine Kinase Inhibitor In

Nonsmall Cell Lung Cancer

Lung Neoplasm

Carcinoma Of Lung

Lung Non-Small Cell Carcinoma

Non-Small Cell Lung Cancer

Nsclc

Lung Neoplasms

Malignant Neoplasm Of Lung

Alveolar Cell Carcinoma

Nonsmall Cell Lung Cancer, Somatic

Nonsmall Cell Lung Cancer, Response To Tyrosine Kinase Inhibitor In

Nonsmall Cell Lung Cancer, Susceptibility To

Lung Cancer, Somatic

Lung Cancer, Resistance To

Cancer Of Lung

Cancer Of Bronchus

Cancer Of The Lung

Lung Malignancies

Lung Malignant Tumors

Malignant Lung Tumor

Malignant Tumor Of Lung

Pulmonary Cancer

Pulmonary Carcinoma

Pulmonary Neoplasms

Respiratory Carcinoma

LNCR

Adenocarcinoma Of Lung

Neoplasm Of Lung

Cancer Lung

Carcinoma Non-Small Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Cancers

Lung Carcinomas

Cancer, Lung

Cancer, Lung, Non-Small Cell

Primary Malignant Neoplasm Of Lung

Bronchioloalveolar Adenocarcinoma

Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Orthologs Information

Species Symbol Source ID
Felis catus DUS2 VGNC VGNC:61658
Rattus norvegicus DUS2 RGD RGD:1305612
Macaca mulatta DUS2 VGNC VGNC:71908
Canis familiaris DUS2 VGNC VGNC:40124
Mus musculus DUS2 MGD MGI:1913619
Bos taurus DUS2 VGNC VGNC:28246